Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS Methylphenidate for Smoking Cessation in ADHD
NCT00253747Phase 3Completed
- Sponsor
- University of Cincinnati
- Start
- Nov 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nicotine dependence comparing Concerta + Nicotine with Placebo + Nicotine (2 arms). Primary endpoint: Prolonged Abstinence. Started Nov 2005; status: completed.
02
Drugs
methylphenidate
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00253747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253747.